4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001415889-25-005908
10% owner bought 122,882 shares at an average $11.45 ($1,407,368)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. 10% owner | 2025-02-10 | Purchase | +574 | $10.90 | $6,257 | 4,026,120 | I |
| Venrock Healthcare Capital Partners III, L.P. 10% owner | 2025-02-11 | Purchase | +9,593 | $10.95 | $105,043 | 4,035,713 | I |
| Venrock Healthcare Capital Partners III, L.P. 10% owner | 2025-02-12 | Purchase | +8,971 | $11.86 | $106,396 | 4,044,684 | I |
| Venrock Healthcare Capital Partners III, L.P. 10% owner | 2025-02-13 | Purchase | +14,950 | $11.63 | $173,869 | 4,059,634 | I |
| Venrock Healthcare Capital Partners III, L.P. 10% owner | 2025-02-14 | Purchase | +88,794 | $11.44 | $1,015,803 | 4,148,428 | I |
| Open-market purchases · 122,882 sh · avg $11.45 · $1,407,368 | |||||||
Loading xslF345X05/form4-02272025_110244.xml…